The 2nd ABAC meeting has been held in Hong Kong from April 22nd to 25th. During the lunch panel on April 24th, Cognitact CEO Stella Ling was invited to the discussion of Global Biotech Innovation from Hong Kong. #ABAC #Cognitact #Alzheimer's Disease #Aging
Cognitact Limited
Health and Human Services
世界頂尖創新科技實現阿茲海默症的早期檢測 World-leading Technology detects Alzheimer's Disease early
About us
【康至德】將前沿研究成果轉化為腦退化症的風險預測、診斷和疾病監測工具，利用血液在症狀出現階段之前檢測出認知障礙症。 At Cognitact, we are translating cutting-edge research efforts into a risk prediction, diagnostic and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood.
- Website
-
cognitact.com
External link for Cognitact Limited
- Industry
- Health and Human Services
- Company size
- 2-10 employees
- Headquarters
- Hong Kong, China
- Type
- Privately Held
- Founded
- 2020
- Specialties
- biotech, 生物科技, biomedical, and 生物醫療
Locations
-
Primary
Get directions
Office 208, 2/F, Building 17W, Hong Kong Science Park, Shatin, N.T.
Hong Kong, China, HK
Employees at Cognitact Limited
-
Paul Li
Venture Partner|Founder of Social Enterprise|Company Advisor and Board Member|Coach/Mentor for Leadership, Career and Change Management
-
Nisa Leung
Managing Partner, Qiming Venture Partners, Forbes Midas Lister
-
Tianyang Wang
Marketing and Medical Director at Cognitact
-
Eunice Yau, MIFA
Sales Operations | Customer Service | Project Management | Student & Parent affairs | Aromatherapist | Rehabilitation | Telecommunications
Updates
-
🎉 Exciting News! Cognitact has been honored with the prestigious "HKCT Business Award 2024 – Most Outstanding Molecular Medicine Enterprise of the Year" by the Hong Kong Commercial Times on March 14, 2024! 🏆 This award is a testament to our relentless efforts and achievements in the field of Alzheimer's disease blood biomarker testing over the past year. The jury conducted a comprehensive assessment based on our accomplishments, market competitiveness, brand philosophy, and professional standing. Looking ahead, we remain committed to the early detection and prevention of Alzheimer's disease, striving to provide cutting-edge technology to patients and enhance our market presence. Thank you for your unwavering support! Together, let's continue our fight against Alzheimer's and shape a brighter future! 💪 #Cognitact #HKCTCorporateAward #OutstandingMolecularMedicineEnterprise #AlzheimersDisease #EarlyDetection
-